Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Hemianopsia 1Brain Neoplasms 1

Interventions

tislelizumab 12Capecitabine 8apatinib 5Surgical Procedures, Operative 5Carboplatin 5Oxaliplatin 4Drug Therapy 4Cisplatin 4Radiation 3Paclitaxel 3Immunotherapy 3Bevacizumab 3toripalimab 2anlotinib 2Standard of Care 2Radiotherapy 2Methods 2Melphalan 2Low-Level Light Therapy 2Letrozole 2Interleukin-2 2Injections 2Cryotherapy 2130-nm albumin-bound paclitaxel 2zanubrutinib 1trastuzumab deruxtecan 1sintilimab 1pyrotinib 1pertuzumab 1obinutuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Photic Stimulation × Clear all
NCT07558395 2026-04-30

REVIIH-BT

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Not yet recruiting
120 enrolled
CNS

Brain Neoplasms, Hemianopsia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡